SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-15-003315
Filing Date
2015-05-05
Accepted
2015-05-05 16:33:22
Documents
11
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q snss-10q_20150331.htm 10-Q 952766
2 EX-31.1 snss-ex311_201503316.htm EX-31.1 13989
3 EX-31.2 snss-ex312_201503317.htm EX-31.2 14252
4 EX-32.1 snss-ex321_201503318.htm EX-32.1 9451
5 GRAPHIC g201505052026436591931.jpg GRAPHIC 2799
  Complete submission text file 0001564590-15-003315.txt   4729433

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT snss-20150331.xml EX-101.INS 657728
7 XBRL TAXONOMY EXTENSION SCHEMA snss-20150331.xsd EX-101.SCH 38618
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE snss-20150331_cal.xml EX-101.CAL 35395
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE snss-20150331_def.xml EX-101.DEF 95413
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE snss-20150331_lab.xml EX-101.LAB 259501
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE snss-20150331_pre.xml EX-101.PRE 181948
Mailing Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-266-3500
SUNESIS PHARMACEUTICALS INC (Filer) CIK: 0001061027 (see all company filings)

IRS No.: 943295878 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-51531 | Film No.: 15833475
SIC: 2834 Pharmaceutical Preparations